Lung Neoplasms: all 7,334 studies

Page 24 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Stereotactic Boost for Locally Advanced Non-Small Cell Lung CancerTerminatedNCT01222572Phase 1/2Results posted
• Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung CancerStatus unknownNCT01218594Phase 2Results posted
• Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck CancerTerminatedNCT01212627Phase 1Results posted
• Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT01211483Phase 1/2Results posted
• Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive StrategyCompletedNCT01209520Not applicableResults posted
• Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By SurgeryTerminatedNCT01207726Phase 2Results posted
• A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)CompletedNCT01204697Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01196078Phase 4Results posted
• Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung CancerCompletedNCT01194453Phase 2Results posted
• RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line ChemotherapyTerminatedNCT01193868Phase 2Results posted
• Using FDG-PET During Radiation Therapy in Non-Small Cell Lung CancerCompletedNCT01190527Not applicableResults posted
• Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or GefitinibTerminatedNCT01189435Phase 2Results posted
• A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)CompletedNCT01183858Phase 3Results posted
• A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line TherapyCompletedNCT01174563Phase 2Results posted
• Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung CancerCompletedNCT01173523Phase 2Results posted
• A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer TumorsCompletedNCT01171924Phase 1Results posted
• A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyCompletedNCT01168973Phase 3Results posted
• Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung CancerCompletedNCT01165216Phase 1Results posted
• A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung CancerCompletedNCT01165021Phase 2Results posted
• An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung CancerCompletedNCT01161173Results posted
• A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01160744Phase 2Results posted
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNCT01147965Phase 1/2Results posted
• A Study in Non Small Cell Lung CancerCompletedNCT01139775Phase 1/2Results posted
• Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC SubjectsCompletedNCT01134016Phase 1Results posted
• Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer PatientsCompletedNCT01133067Results posted
• Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung CancerCompletedNCT01126736Phase 1/2Results posted
• A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.CompletedNCT01124864Phase 2Results posted
• A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung CancerCompletedNCT01121575Phase 1Results posted
• Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung CancerCompletedNCT01109524Phase 2Results posted
• Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01108666Phase 2Results posted
• Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT01107626Phase 3Results posted
• Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung CancerCompletedNCT01107444Phase 2Results posted
• Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung CancerCompletedNCT01104155Phase 2Results posted
• Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)CompletedNCT01102231Phase 2Results posted
• Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT01101334Phase 2Results posted
• A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)CompletedNCT01100931Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung CancerCompletedNCT01077713Phase 2Results posted
• A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT01076504Phase 2Results posted
• Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryCompletedNCT01076231Phase 1/2Results posted
• Lung Cancer Exercise Training StudyCompletedNCT01068210Not applicableResults posted
• Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLCCompletedNCT01063283Not applicableResults posted
• Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT01055197Phase 2Results posted
• GW786034 in Patients With Non Small Cell Lung Cancer 3rd LineTerminatedNCT01049776Phase 2Results posted
• Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal MalignanciesCompletedNCT01045421Phase 1/2Results posted
• Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLCCompletedNCT01042288Phase 2Results posted
• Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT01041781Phase 3Results posted
• Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01040780Phase 3Results posted
• Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung CancerTerminatedNCT01038752Phase 2Results posted
• Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)TerminatedNCT01029925Phase 2Results posted
• Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung CancerCompletedNCT01027598Phase 2Results posted
• Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01026844Phase 1Results posted
• A Study for Participants With Small-Cell Lung CancerCompletedNCT01025284Phase 2Results posted
• A Study in Non-squamous Non Small Cell Lung Cancer in Asian PatientsCompletedNCT01020786Phase 4Results posted
• A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung CancerCompletedNCT01017874Phase 3Results posted
• Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTerminatedNCT01017601Phase 2Results posted
• Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Motion and Lung Function (GCC 0943)CompletedNCT01016938Results posted
• Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian PopulationTerminatedNCT01015443Phase 3Results posted
• Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung CancerCompletedNCT01011075Phase 2Results posted
• A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung CancerCompletedNCT01005680Phase 3Results posted
• Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung CancerTerminatedNCT01004510Phase 2Results posted
• A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung CancerCompletedNCT01000480Phase 2Results posted
• PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCompletedNCT01000025Phase 3Results posted
• Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLCCompletedNCT00997334Phase 2Results posted
• Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)CompletedNCT00995761Phase 2Results posted
• A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00994123Phase 1/2Results posted
• A Study of Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00988858Phase 2Results posted
• Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsTerminatedNCT00988169Phase 2Results posted
• Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00986674Phase 2Results posted
• Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT00984542Phase 2Results posted
• First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinCompletedNCT00982111Phase 3Results posted
• First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-CisplatinCompletedNCT00981058Phase 3Results posted
• Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00979212Phase 2Results posted
• A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)CompletedNCT00978250Phase 2Results posted
• Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung CancerTerminatedNCT00976677Phase 2Results posted
• Figitumumab Combined With Pegvisomant For Advanced Solid TumorsTerminatedNCT00976508Phase 1Results posted
• Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung CancerCompletedNCT00976456Phase 3Results posted
• Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00970684Phase 2Results posted
• Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung CancerCompletedNCT00965731Phase 1Results posted
• Validation of a Screening Tool in Geriatric OncologyCompletedNCT00963911Not applicableResults posted
• A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLCCompletedNCT00963807Phase 2Results posted
• AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT00961415Phase 3Results posted
• Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung CancerCompletedNCT00960999Phase 2Results posted
• Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLCTerminatedNCT00960297Phase 2Results posted
• Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary ChemoradiotherapyCompletedNCT00960115Phase 1/2Results posted
• Acceptability of Less Harmful Alternatives to CigarettesCompletedNCT00957424Not applicableResults posted
• Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerTerminatedNCT00955305Phase 2Results posted
• Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung CancerCompletedNCT00950365Phase 2Results posted
• An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00949910Phase 4Results posted
• Study of Participants With Advanced Non-Small Cell Lung CancerCompletedNCT00948675Phase 3Results posted
• S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerTerminatedNCT00946712Phase 3Results posted
• Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00942825Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00940875Phase 2Results posted
• Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung CancerTerminatedNCT00932152Phase 2Results posted
• A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung CancerTerminatedNCT00924209Phase 2Results posted
• Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung CancerTerminatedNCT00923949Phase 2Results posted
• A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00918203Phase 2Results posted
• Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional RecurrenceCompletedNCT00915005Phase 2Results posted
• Testing of Computer Aided Detection Software for Riverain Medical GroupCompletedNCT00906789Results posted
• Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung CancerCompletedNCT00906282Phase 2Results posted
• Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 2Results posted

← Lung Neoplasms overview